Assignee
GENOR BIOPHARMA CO LTD
CN·2 granted patents·2 pending applications·0 citations·filing 2014–2022
Top patents by PatentIndex Score
4 records- 0149US2025346668A1Cd3-targeting antibody and use thereofGENOR BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 0243US2020332248A1Staged-retention method for upstream production of biomacromolecules, production module used therein and application thereof in productionGENOR BIOPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 0342US10017555B2Long-acting blood sugar decreasing fusion proteinGENOR BIOPHARMA CO LTD·Filed 2014·Granted Jul 10, 2018·0 cites·14 claims
- 0434US10253108B2Mutated antibody of fully humanized HER2 antibody, and encoding gene and use thereofGENOR BIOPHARMA CO LTD·Filed 2015·Granted Apr 9, 2019·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when GENOR BIOPHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →